US · RYAN · INSURANCE - SPECIALTY
Ryan Specialty Holdings, Inc. (RYAN) intrinsic value and stock valuation
$47.09as of 2026-11-21 · Mkt cap 5.83B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Ryan Specialty Holdings, Inc. DCF and intrinsic value
InvestorsCraft values RYAN with the Chepakovich two-stage DCF model — currently rated undervalued. How the model works · Run your own DCF prefilled from RYAN’s statements →
Ryan Specialty Holdings, Inc. Graham Number
Graham Number: $10.51d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2019–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Arch Capital Group Ltd. (ACGL) $108.82
- RenaissanceRe Holdings Ltd. (RNR) $343.97
- Voya Financial, Inc. (VOYA) $95.50
- Lincoln National Corporation (LNC) $39.68
- BOK Financial Corporation (BOKF) $124.51
- First American Financial Corporation (FAF) $64.58
- MGIC Investment Corporation (MTG) $26.68
- Essent Group Ltd. (ESNT) $64.42
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $3.05B | $2.52B | $2.08B | $1.73B | $1.43B |
| Operating income | $625.2M | $272.6M | $237.9M | $179.2M | $61.6M |
| Net income | $63.4M | $94.7M | $61M | $61.1M | $65.9M |
| EPSd | $227.6K | $344.5K | $485.4K | $229.7K | $623K |
| Operating cash flow | $643.7M | $514.9M | $477.2M | $335.5M | $273.5M |
| Capital expenditure | -$-67.95M | -$-47M | -$-29.78M | -$-15.04M | -$-9.78M |
| Free cash flow | $575.7M | $467.9M | $447.4M | $320.5M | $263.7M |
| Total assets | $10.6B | $9.65B | $7.25B | $6.38B | $5.46B |
| Total debt | $3.53B | $3.46B | $2.16B | $2.16B | $1.68B |
| Net debt | $3.37B | $2.92B | $1.32B | $1.16B | $1.3B |
| Total equity | $1.25B | $1.1B | $979.6M | $817.8M | $594.8M |
| Cash and short-term investments | $158.3M | $554.1M | $838.8M | $992.7M | $387M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $3.05B | $2.52B | $2.08B | $1.73B | $1.43B |
| Cost of revenue | $287.5M | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $2.76B | $2.52B | $2.08B | $1.73B | $1.43B |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $453.5M | $1.94B | $1.6B | $1.33B | $1.13B |
| Other expenses | $1.68B | $300M | $242.4M | $220.1M | $240.6M |
| Operating expenses | $2.14B | $2.24B | $1.84B | $1.55B | $1.37B |
| Cost and expenses | $2.43B | $2.24B | $1.84B | $1.55B | $1.37B |
| Interest income | $56.5M | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest expense | $222.4M | $158.5M | $119.5M | $104.8M | $79.4M |
| Depreciation and amortization | $287.5M | $167.6M | $115.8M | $109.3M | $112.7M |
| Ebitda | $803.1M | $598.6M | $473.3M | $393.3M | $253.6M |
| Operating income | $625.2M | $272.6M | $237.9M | $179.2M | $61.6M |
| Total other income/expenses, net | -$-332.05M | $0.00 | $0.00 | $0.00 | $0.00 |
| Income before tax | $293.2M | $272.6M | $237.9M | $179.2M | $61.6M |
| Income tax expense | $79M | $42.6M | $43.5M | $15.9M | $4.93M |
| Net income | $63.4M | $94.7M | $61M | $61.1M | $65.9M |
| Weighted average shares outstanding | $127.3M | $120.8M | $114.4M | $108.6M | $105.7M |
| Weighted average diluted shares outstanding | $278.5M | $274.8M | $125.8M | $265.8M | $105.7M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $158.3M | $554.1M | $838.8M | $992.7M | $387M |
| Net receivables | $489M | $4.17B | $3.46B | $2.87B | $2.6B |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current assets | $647.3M | $4.81B | $4.35B | $3.91B | $3.04B |
| Property, plant and equipment, net | $199.9M | $183.5M | $170.1M | $175.1M | $100.2M |
| Goodwill and intangible assets | $3.34B | $4.12B | $2.26B | $1.8B | $1.88B |
| Long-term investments | $110M | $70.9M | $46.1M | $38.5M | $45.4M |
| Total non-current assets | $9.92B | $4.84B | $2.9B | $2.47B | $2.42B |
| Total assets | $10.6B | $9.65B | $7.25B | $6.38B | $5.46B |
| Accounts payable | $217.3M | $0.00 | $0.00 | $0.00 | $0.00 |
| Short-term debt | $86.2M | $73.8M | $56.7M | $53.3M | $42.3M |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $86.2M | $649.5M | $501.3M | $414.3M | $433.6M |
| Long-term debt | $3.44B | $3.39B | $2.1B | $2.1B | $1.64B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $9.22B | $7.9B | $5.77B | $5.15B | $4.43B |
| Capital lease obligations | $179.1M | $181.3M | $175.8M | $174.7M | $93.2M |
| Total liabilities | $9.31B | $8.55B | $6.27B | $5.57B | $4.86B |
| Common stock | $270K | $260K | $260K | $260K | $260K |
| Retained earnings | $120.4M | $122.9M | $114.4M | $54M | -$-7.06M |
| Accumulated other comprehensive income (loss) | $13.9M | -$-1.8M | $3.08M | $6.04M | $1.71M |
| Total equity | $1.25B | $1.1B | $979.6M | $817.8M | $594.8M |
| Total investments | $110M | $84.8M | $46.1M | $38.5M | $45.4M |
| Total debt | $3.53B | $3.46B | $2.16B | $2.16B | $1.68B |
| Net debt | $3.37B | $2.92B | $1.32B | $1.16B | $1.3B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $214.2M | $229.9M | $194.5M | $163.3M | $56.6M |
| Depreciation and amortization | $287.5M | $167.6M | $115.8M | $109.3M | $112.7M |
| Stock-based compensation | $38.8M | $79M | $69.7M | $77.5M | $67.5M |
| Change in working capital | -$-37.28M | -$-29.38M | $37.9M | -$-74.99M | -$-29.44M |
| Accounts receivable | -$-57.56M | -$-22.01M | -$-44.19M | -$-20.37M | -$-29.66M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts payable | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash provided by operating activities | $643.7M | $514.9M | $477.2M | $335.5M | $273.5M |
| Investments in property, plant and equipment | -$-67.95M | -$-47M | -$-29.78M | -$-15.04M | -$-9.78M |
| Acquisitions, net | -$-746.49M | -$-1.71B | -$-446.68M | $0.00 | -$-108.88M |
| Net cash used for investing activities | -$-834.01M | -$-1.76B | -$-476.23M | -$-22.42M | -$-457.94M |
| Common stock issued | $0.00 | $0.00 | $0.00 | $0.00 | $1.45B |
| Common stock repurchased | -$-3.73M | -$-27.46M | -$-8.79M | -$-7.17M | -$-967.85M |
| Dividends paid | -$-62.34M | -$-80.24M | -$-71.67M | -$-39.88M | -$-47.1M |
| Net cash used for financing activities | $78.1M | $1.17B | -$-12.61M | $314.8M | $429.3M |
| Net change in cash | -$-96.33M | -$-75.53M | -$-11.05M | $627.7M | $244M |
| Cash at end of period | $1.58B | $1.68B | $1.76B | $1.77B | $1.14B |
| Operating cash flow | $643.7M | $514.9M | $477.2M | $335.5M | $273.5M |
| Capital expenditure | -$-67.95M | -$-47M | -$-29.78M | -$-15.04M | -$-9.78M |
| Free cash flow | $575.7M | $467.9M | $447.4M | $320.5M | $263.7M |
Line items
Line items
Line items
About Ryan Specialty Holdings, Inc.
Ryan Specialty Holdings, Inc. functions as a provider of specialized insurance products and comprehensive solutions for the benefit of insurance brokers, agents, and carriers. The company delivers a range of services including distribution, underwriting, product development, administration, and risk management, primarily through its roles as a wholesale broker and a managing underwriter. This firm, established in 2010, maintains its headquarters in Chicago, Illinois.
- CEO
- Timothy William Turner
- Employees
- 6.14K
- Beta
- 0.60
Explore
Frequently asked questions
What is the intrinsic value of Ryan Specialty Holdings, Inc. (RYAN)?
Ryan Specialty Holdings, Inc. (RYAN) is currently undervalued based on the InvestorsCraft IC model — IC value is 20–50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is RYAN undervalued?
RYAN trades at a price of $47.09 (Nov 21, 2026): undervalued — IC value is 20–50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.